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Purpose: Polymorphisms of the cluster of differentiation 40 (CD40) gene have recently been identified to be associated
with the risk to several immune diseases. The aim of this study was to determine the potential association of CD40
polymorphisms with Fuch uveitis syndrome (FUS).
Methods: A total of 131 Han Chinese patients with FUS and 402 healthy controls were genotyped using the polymerase
chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Genotype counts in patients and controls
were analyzed by the χ2 test.
Results:  All  genotypic  and  allelic  frequencies  of  the  tested  two  CD40  polymorphisms  were  in  Hardy–Weinberg
equilibrium. The genotypic and allelic frequencies of rs4810485 and rs1883832 were not different between patients with
FUS and controls. No influence of sex could be found following stratification analysis according to gender.
Conclusions: Our results suggest that the two investigated single-nucleotide polymorphisms (SNPs), rs4810485 and
rs1883832, in CD40 are not associated with FUS in the Han Chinese population.
Fuchs uveitis syndrome (FUS) is a chronic unilateral
ocular  inflammatory  disease  which  mainly  affects  young
adults. It is a relatively common uveitis entity in China and is
characterized by medium-sized or stellate keratic precipitates,
a variable degree of iris depigmentation or heterochromia
without posterior synechiae [1]. Although the etiology of FUS
has not yet been fully elucidated [2], both environmental and
genetic risk factors have been suggested to be involved in its
pathogenesis. Several groups have identified an association
with rubella infection and FUS [3] and a decline has been
noted  in  the  incidence  which  is  ascribed  to  vaccination
programs  against  rubella.  Earlier  studies  showed  an
association of the human leukocyte antigen-B18 (HLA-B18)
with FUS [4]. Furthermore, recent studies have addressed the
association of polymorphisms of the intercellular adhesion
molecule 1 (ICAM-1) gene [5], the cytotoxic T cell antigen
(CTLA) 4 gene [6], and the interleukin 23 receptor (IL23R)
gene [7] with this disease.
The cluster of differentiation 40 (CD40) gene is located
on chromosome 20q13 and encodes the CD40 protein, which
plays an important role in the onset and severity of multiple
inflammatory  autoimmune  diseases  and  the  initiation  and
maintenance of inflammation triggered by infections through
interaction  with  its  ligand  (cluster  of  differentiation  154
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[CD154])  [8].  Recently,  genome-wide  association  surveys
have  identified  the  association  at  the  CD40  locus  with
rheumatoid arthritis [8] and multiple sclerosis [9]. Multiple
candidate gene studies have also identified and validated the
association of several SNPs in CD40 with autoimmune or
autoinflammatory diseases including Graves’ disease [10],
Crohn's  disease,  multiple  sclerosis  [11],  and  rheumatoid
arthritis [12]. As CD40-CD40L binding is required in the
priming of cluster of differentiation 8+ (CD8+) T cell following
virus infection, the CD40 polymorphism might influence the
cytotoxic T cell responses in the virus infection associated
diseases,  such  as  FUS  which  has  been  reported  to  be
associated with rubella and CMV infection. Therefore, we
investigated the association of rs4810485 and rs1883832 at
the CD40 locus with FUS. Unfortunately, we failed to find
any association of its polymorphisms with this disease in a
Han Chinese population.
METHODS
Patients and healthy controls: A total of 131 Han Chinese
patients with FUS and 402 age-, sex-, and ethnic-matched
healthy controls were consecutively recruited from the Uveitis
Study Center of the Sun Yat-sen University (Guangzhou, P.R.
China) and the First Affiliated Hospital of Chongqing Medical
University (Chongqing, P.R. China). The diagnosis of FUS
was  made  according  to  the  clinical  manifestations  as
described  earlier  [1]  Briefly,  the  clinical  manifestations
include low-grade anterior chamber response, characteristic
medium-sized or stellate keratic precipitates, and diffuse iris
depigmentation  or  heterochromia  without  posterior
Molecular Vision 2011; 17:2469-2472 <http://www.molvis.org/molvis/v17/a267>
Received 12 July 2011 | Accepted 15 September 2011 | Published 23 September 2011
© 2011 Molecular Vision
2469synechiae.  The  Ethics  Committees  of  the  First  Affiliated
Hospital  of  Chongqing  Medical  University  approved  the
study.  The  tenets  of  the  Declaration  of  Helsinki  were
conducted during all procedures of this present study. The
donors were enrolled in the study after informed consent.
Genomic DNA extraction and genotyping:  Blood samples
were collected in EDTA tubes and kept at −70 °C until use.
Genomic DNA was isolated using the QIAamp DNA Blood
Mini Kit (Qiagen, Valencia, CA ). The primers of the CD40
gene polymorphisms listed in Table 1 were used to amplify
the target DNA by the polymerase chain reaction (PCR). Each
PCR reaction was conducted in 10 μl containing 5 μl Premix
Taq  (Ex  Taq  Version;  TaKaRa  Biotechnology  Co.  Ltd.,
Dalian, China), 20 pmol primers, and 0.2 μg of genomic DNA
for amplification of the DNA. The conditions were as follows:
initial denaturation at 95 °C for 5 min followed by 38 cycles
of denaturation at 95 °C for 30 s, annealing at 58 °C for 30 s,
extension at 72 °C for 25 s, and a final extension at 72 °C for
5  min.  The  two  tested  SNPs  were  genotyped  by  PCR-
restriction fragment length polymorphism (RFLP) analysis.
PCR  products  of  the  rs4810485  and  rs1883832
polymorphisms were respectively digested with 4 U of MspI
(Fermentas International Inc., Burlington, Canada) and NcoI
(Fermentas International Inc.; Table 1) in a 10 μl reaction
volume  overnight.  The  amplified  PCR  products  were
electrophoresed  on  a  3.5%  agarose  gel  and  stained  with
GoldView™ (SBS Genetech, Beijing, China). The results
were validated by direct sequencing by the Majorbio Bio-
Pharm Technology Company (Shanghai, China) in 10% of the
total samples.
Statistical  analysis:  Hardy–Weinberg  equilibrium  (HWE)
was  evaluated  in  the  subjects  using  the  chi-square  test.
Genotype frequencies were obtained by direct counting. The
statistical analysis was performed using the χ2 test with SPSS
(version  17.0;  SPSS  Inc.,  Chicago,  IL)  to  compare  the
genotype and allele frequencies between patients and controls.
We used Bonferroni correction to account for multiple testing.
The statistical significance was set at pc<0.05.
RESULTS
One hundred and thirty-one consecutive Han Chinese patients
with FUS were enrolled in the present study (72 males and 59
females). The average age of the patients with FUS in the
present study was 38.2±10.1 years (age range 16–68 years).
The healthy controls consisted of 402 subjects (241 males and
161 females), in which the average age was 37.2±10.6 years
(age range 12–72 years). The age and gender distribution of
the patients with FUS and controls are summarized in Table
2.
Two single-nucleotide polymorphisms (SNPs) of CD40
(rs4810485 and rs1883832) were successfully genotyped in
131 patients with FUS and 402 healthy controls. The results
showed  that  the  distribution  of  genotypes  and  alleles  in
subjects were in HWE. The distribution of genotypic and
allelic frequencies of the tested two CD40 polymorphisms is
presented  in  Table  3.  A  trend  of  increased  frequency  of
genotype of rs4810485 TT and rs1883832 TT was observed
in  the  Fuchs’  patient  cohort  as  compared  with  controls.
However  there  was  no  statistically  significant  difference
concerning the genotype and allele of both rs4810485 and
rs1883832 SNPs between Fuchs’ patients and controls. In
TABLE 1. PRIMERS OF CD40 SNPS AND RESTRICTION ENZYMES FOR RFLP ANALYSIS
Rs number Primers Restriction enzyme
rs4810485 5′-TATTTTTGTAGTTCCTCATTCTG-3′ MspI
  5′-GCCCCCCTTTACCTCTTTC-3′  
rs1883832 5′-CCCCGATAGGTGGACCGCGATTG-3′ NcoI
  5′-CCCGCCCTCTGAACCCCCTACCA-3′  
               RFLP, restriction fragment length polymorphism.
TABLE 2. AGE AND GENDER DISTRIBUTION IN FUCHS’ PATIENTS AND CONTROLS.
 
Patients with FUS Healthy controls
Clinical features Total (n=131) % Total (n=402) %
Age (mean ±SD) 38.2±10.1   37.2±10.6  
Range 16–68   12–72  
Sex
Male 72 55 241 60
Female 59 45 161 40
                FUS: Fuchs uveitis syndrome.
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polymorphisms with FUS by stratification analysis according
to gender.
DISCUSSION
No  association  was  found  between  the  rs4810485  and
rs1883832  polymorphisms  of  CD40  with  FUS  in  a  Han
Chinese population.
CD40 is a T cell membrane protein which is critical for
CD8+ T cell differentiation and the CD8+ T cell-mediated
response [13-15]. CD40 is expressed on antigen-presenting
cells  (APCs)  such  as  macrophages  and  B  cells.  CD40
stimulation contributes to APC activation and is required for
the priming of CD8+ cytotoxic T cell (CTL) and CD4-cell
dependent CTL responses to some viruses through interaction
with CD154. The interaction of CD40 and CD154 have been
shown to play a role in various diseases such as autoimmune
thyroiditis,  type  1  diabetes,  inflammatory  bowel  disease,
psoriasis,  multiple  sclerosis,  rheumatoid  arthritis,  and
systemic  lupus  erythematosus  [16].  Earlier  studies  have
shown that CD8+ T cells are predominant cells in the aqueous
humor  in  patients  with  FUS  [17],  suggesting  a  possible
involvement of CD40 in the pathogenesis of this disease.
As there are many SNPs in a candidate gene and only few
SNPs may contribute to the disease, it is very important to
determine how many and which SNPs should be selected as
optimal candidates within the gene to test an association with
disease.  In  the  present  study,  we  chose  rs4810485  and
rs1883832 as the tested SNPs because these were also used in
earlier studies [8,11]. rs4810485 was shown to be associated
with rheumatoid arthritis risk in Caucasians [8], but not in
patients with a Korean ancestry [18]. Our findings showing
that rs4810485 was not associated with FUS could therefore
also be due to the ethnic background of our patients.
We also investigated rs1883832, whereby the common
variant increases the efficiency of CD40 translation and which
has been associated with Graves’ disease [19,20], multiple
sclerosis,  and  Crohn’s  disease  [12].  Of  interest  is  the
observation that the minor allele rs1883832 T is protective in
Graves’  disease  but  enhances  risk  of  disease  in  Crohn’s
disease  and  multiple  sclerosis  [12].  We  were  not  able  to
demonstrate  an  association  between  rs1883832
polymorphisms and FUS.
Associations between CD40 polymorphisms have mainly
been shown in autoimmune diseases and the absence of an
association with FUS may be due to its infectious etiology
[16,21]. Recent studies have for instance detected rubella
virus in the anterior chamber and have shown an increased
intraocular rubella antibody production in these patients [22].
Since association studies may be influenced by numerous
factors, the following measures were used to validate the
results. The healthy controls and patients were strictly age-,
sex-,  and  ethnically  matched.  To  validate  the  result  of
genotyping by PCR-RFLP, 10% of samples were directly
sequenced.
It  is  worthwhile  to  point  out  that  there  are  some
limitations in the present study. The sample of the patients was
relatively small and only Han Chinese cohorts were included.
Therefore, our study is relatively under-powered to examine
an association with Fuchs’ patients. Larger sample size is
needed to detect the association of CD40 with this disease.
Although we failed to find any association between FUS and
the investigated two SNPs which have been shown to be
associated with several diseases, our result does not rule out
the possibility that other SNPs of CD40 are associated with
this  disease.  Therefore,  study  is  needed  to  clarify  the
association of other SNPs of CD40 with this disease.
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